BR0114104A - Combinações microbianas óticas para tratamento de animais com membrana do tìmpano rompida - Google Patents

Combinações microbianas óticas para tratamento de animais com membrana do tìmpano rompida

Info

Publication number
BR0114104A
BR0114104A BR0114104-0A BR0114104A BR0114104A BR 0114104 A BR0114104 A BR 0114104A BR 0114104 A BR0114104 A BR 0114104A BR 0114104 A BR0114104 A BR 0114104A
Authority
BR
Brazil
Prior art keywords
optical
treatment
tympanic membrane
animal treatment
ruptured
Prior art date
Application number
BR0114104-0A
Other languages
English (en)
Inventor
Daniel Ciszewski
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Publication of BR0114104A publication Critical patent/BR0114104A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMBINAçõES MICROBIANAS óTICAS PARA TRATAMENTO DE ANIMAIS COM MEMBRANA DO TìMPANO ROMPIDA". A presente invenção refere-se uma composição aperfeiçoada que é de utilidade no tratamento de infecções óticas, compreendendo um agente antimicrobiano e sulfadiazina de prata, em uma combinação terapeuticamente efetiva para tratar de infecções óticas em animais, o aperfeiçoamento compreendendo a composição que pode ser seguramente no tratamento de animais com membrana de tímpano rompida.
BR0114104-0A 2000-09-25 2001-09-19 Combinações microbianas óticas para tratamento de animais com membrana do tìmpano rompida BR0114104A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66951400A 2000-09-25 2000-09-25
PCT/US2001/029840 WO2002026219A2 (en) 2000-09-25 2001-09-19 Otic microbial combinations for treatment of animals with ruptured tympanic membrane

Publications (1)

Publication Number Publication Date
BR0114104A true BR0114104A (pt) 2003-07-29

Family

ID=24686615

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0114104-0A BR0114104A (pt) 2000-09-25 2001-09-19 Combinações microbianas óticas para tratamento de animais com membrana do tìmpano rompida

Country Status (12)

Country Link
US (1) US7011839B2 (pt)
EP (1) EP1331945A2 (pt)
JP (1) JP2004509918A (pt)
KR (1) KR20030033076A (pt)
CN (1) CN1529620A (pt)
AU (1) AU2001291219A1 (pt)
BR (1) BR0114104A (pt)
CA (1) CA2425749A1 (pt)
HU (1) HUP0303696A3 (pt)
MX (1) MXPA03002342A (pt)
WO (1) WO2002026219A2 (pt)
ZA (1) ZA200302274B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2394390B (en) * 2002-10-18 2005-07-06 Ipwireless Inc Arrangement and method for RF filter
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
CA2622002A1 (en) * 2005-09-26 2007-04-05 Piedmont Pharmaceuticals Llc Methods for treatment and prevention of otitis media using nonionic surfactants to facilitate transmembrane drug delivery into the middle ear
AU2006295236A1 (en) * 2005-09-26 2007-04-05 Piedmont Pharmaceuticals Llc Methods for treatment and prevention of otitis media using chemical penetration enhancers to facilitate transmembrane drug delivery into the middle ear
US10046079B2 (en) 2013-03-15 2018-08-14 Materials Modification Inc. Clay composites and their applications
CN103340878B (zh) * 2013-07-05 2015-03-04 成都乾坤动物药业有限公司 一种兽用复方氧氟沙星溶液及其制备工艺
JP7033789B2 (ja) * 2016-06-29 2022-03-11 オトノミー，インク． トリグリセリド耳用製剤とその使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3761590A (en) * 1970-05-18 1973-09-25 Research Corp Silver sulfadiazine used in the treatment of burns
US4404197A (en) * 1981-05-15 1983-09-13 Fox Jr Charles L Antimicrobial compositions containing 1-ethyl-6-fluoro-1,4-dihydro-4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline carboxylic acid or metal salts thereof and silver sulfadiazine
JPH01258620A (ja) * 1988-04-08 1989-10-16 Dai Ichi Seiyaku Co Ltd 耳疾患用局所製剤
NZ309624A (en) * 1995-06-06 1999-04-29 Bayer Ag Non-irritating, non-sensitizing, non-ototoxic (harmful to the ears) antibacterial compositions
US5753269A (en) * 1995-12-27 1998-05-19 Bayer Corporation Otic microbial combinations

Also Published As

Publication number Publication date
CN1529620A (zh) 2004-09-15
HUP0303696A2 (hu) 2004-05-28
US7011839B2 (en) 2006-03-14
US20030119804A1 (en) 2003-06-26
KR20030033076A (ko) 2003-04-26
CA2425749A1 (en) 2002-04-04
JP2004509918A (ja) 2004-04-02
WO2002026219A3 (en) 2003-03-27
EP1331945A2 (en) 2003-08-06
HUP0303696A3 (en) 2005-05-30
WO2002026219A2 (en) 2002-04-04
ZA200302274B (en) 2004-06-14
AU2001291219A1 (en) 2002-04-08
MXPA03002342A (es) 2004-10-15

Similar Documents

Publication Publication Date Title
ES2176692T3 (es) Composiciones cosmeticas, dermofarmaceuticas o veterinarias para el tratamiento aseptico de la piel humana o animal.
BR9909668A (pt) Uso de compostos de organofósforo para o tratamento terapêutico e profilático de infecções
AR012241A1 (es) Composicion de depuracion antimicrobiana mantenible y metodos para proporcionar efectividad residual y para tratar acne.
BR9911647A (pt) Composição para banho de imersão para teta de mamìferos, agente condicionante da pele, processo para proteger contra a infecção em uma teta de mamìfero, e, filme protetor
BR0013010A (pt) Formulação de cloreto de sódio de moxifloxacina
BR0214583A (pt) Formulações compreendendo um composto de cefalosporina e seus usos no tratamento de infecções bacterianas em gatos e cães
EP1330221A4 (en) PHARMACEUTICAL COMPOSITIONS, DRESSINGS AND METHODS FOR TREATING MICROBIAL INFECTIONS OF SKIN LESIONS
DE69629519D1 (de) Stable Komplexen von vernetzten Polyvinylpyrrolidone und Iod und Verfahren zur Herstellung
TR200400363T4 (tr) Antibiyotikten / Antibiyotiklerden oluşan bir preparatın imalatı ve kullanımı
PT1056454E (pt) Utilizacao de compostos macrolido para o tratamento do glaucoma
DE60012610D1 (de) Selektive antibakterielle Zusammensetzungen
BR0114104A (pt) Combinações microbianas óticas para tratamento de animais com membrana do tìmpano rompida
BR9406594A (pt) Formulação tópica e processos para sua preparação e para o tratamento e prevenção de parasitas internos e externos de animais
ES2163186T3 (es) Composicion que comprende mupirocina y clorhexidina.
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
DE60031016D1 (de) Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen
BR0113062A (pt) Derivados de heterociclilalquilazol e seu emprego como agente para o combate de parasitas
PT1135020E (pt) Tratamentos para a loque
AR013480A1 (es) 9a-azalidas como agentes antimicrobicos veterinarios
ES2104223T3 (es) 2-((2-(n-isobutil-n-metil)amino)-bencilsulfinil)bencimidazol como agente antimicrobiano contra helicobacter pylori.
ATE283055T1 (de) 8a-azaliden als antimikrobielle agenten
DK1049480T3 (da) Antiviralt middel af planteoprindelse
PT1052991E (pt) Utilizacao de loperamida para o tratamento de infeccoes microbianas
BR0112369A (pt) Anti-helmìnticos para evitar infecções parasitárias no homem e animal ii
BR9611759A (pt) Processo para o tratamento ou prevenção de mucosite oral em um animal, e, composição para administração oral tópica de um peptìdeo antimicrobiano

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 1964 DE 26/08/2008 E CONSIDERANDO A AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS.